The Perioperative Management of Antithrombotic Therapies Using Enoxaparin.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28480651)

Published in J Korean Med Sci on June 01, 2017

Authors

Hun Gyu Hwang1, So My Koo2, Soo Taek Uh2, Yang Ki Kim3

Author Affiliations

1: Depertment of Internal Medicine, Soonchunhyang University Gumi Hospital, Gumi, Korea.
2: Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
3: Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea. kyklung@schmc.ac.kr.

Articles cited by this

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.29

Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med (2013) 5.19

Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med (2003) 5.02

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med (1996) 4.70

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation (2012) 4.33

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med (2002) 3.96

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation (2012) 3.74

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.74

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 3.11

Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med (2004) 2.76

Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology (2001) 2.41

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation (2004) 2.05

Periprocedural Management of Direct Oral Anticoagulants: Comment on the 2015 American Society of Regional Anesthesia and Pain Medicine Guidelines. Reg Anesth Pain Med (2016) 1.60

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost (2006) 1.52

Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis. Thromb Haemost (1984) 1.24

Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost (2007) 1.23

Risk of stroke after surgery in patients with and without chronic atrial fibrillation. J Thromb Haemost (2010) 1.13

Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial. J Thromb Haemost (2014) 1.00

Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines. J Korean Med Sci (2014) 0.92

Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart (2003) 0.92

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res (2001) 0.91

Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol (2010) 0.85

Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med (2010) 0.79

Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin? Catheter Cardiovasc Interv (2009) 0.79

Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement. Thromb Haemost (2014) 0.77

Modern management of prosthetic valve anticoagulation. Mayo Clin Proc (1998) 0.77

Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question. Mayo Clin Proc (2008) 0.77